-
Report details
-
11
Figures
-
6
Tables
-
Market Analysis: Infectious Disease Testing
-
Overview of Infectious Disease Testing
-
Market Outlook
-
Regional Market
-
Company Briefs
-
Roche
-
Abbott
-
Danaher
-
Other Participants
-
Executive News Briefing
-
Briefings
-
Dxcover Limited Raises New Capital
-
Cubit Diagnostics Awarded NIH Funding
-
CARB-X Funds AstraDx’s Neonatal Sepsis Rapid Test
-
Freenome Raises Additional $254 Million
-
Renovaro Secures $15 Million in New Capital
-
Ataraxis AI Secures $20.4 Million in Funding
-
MSInsight Nabs €1.6 Million Seed Funding
-
C2N Diagnostics Receives $10 Million Investment
-
Financial Highlights: Guardant Health, Roche
-
Guardant Reports Strong Demand – Increasing Revenues +31% Over Previous Year
-
Roche Diagnostic Sales Grow 4% CER in 2024 – Supported by Demand for Immunodiagn…
-
Diagnostic Market Mergers, Acquisitions, and Partnership Deals
-
Mergers and Acquisitions
-
Partnerships and Collaborations
-
Industry Watch
-
Industry Watch COVID-19/Flu Update
-
Region Watch
-
Broad-based Company Announcements
-
Announcements
-
AliveDx Nabs CE Mark for Expanded Autoimmune Menu
-
Beckman Coulter Received FDA Breakthrough Device Designation
-
Beckton Dickinson to Spin Off Bioscience and Diagnostic Business
-
GRAIL Provides Galleri Multi-Cancer Early Detection Test Through Quest
-
Molecular Instruments RNA-ISH Enables Breakthrough LDT
-
Roche Snags FDA Clearance for Preeclampsia Test
-
CytoChip Receives FDA Clearance and CLIA Waiver
-
Cicero Diagnostics Unveiled Endometriosis Detection LDT
-
bioMérieux Secures FDA Clearance for BIOFIRE FILMARRAY GI Panel
-
Beckman Coulter Gains Clearance for its DxC 500i
|
In Vitro Diagnostics Business Outlook, Volume 4, Issue 2 - Focus on Infectious Disease Testing
3 Apr 2025
The in vitro diagnostics (IVD) sector stands as a cornerstone of modern healthcare, empowering clinicians with the tools to detect diseases, monitor health conditions, and guide precise treatment decisions.
As healthcare evolves, the IVD market is poised for transformative growth. With the rising prevalence of chronic conditions such as diabetes and cardiovascular diseases, as well as ongoing threats from infectious diseases like COVID-19 and emerging variants, the demand for innovative diagnostic solutions has never been greater.
In Vitro Diagnostics Business Outlook is a bimonthly publication, delivering six issues annually, each dedicated to a different segment of the IVD industry. It provides exclusive insights and data, including:
- Market Data and Forecasts: Detailed growth rates, market size, and market share to identify new opportunities.
- Comprehensive Market View: Coverage of test categories and company profiles.
- M&A Activities: Updates on mergers, acquisitions, partnerships, and collaborations.
- Industry & Region Watch: Tailored strategies based on regional and industry-specific trends.
- News Analysis: In-depth reporting on significant news and events, including exclusive information not readily available elsewhere.
Page Count: 40
Table of Contents
-
Market Analysis: Infectious Disease Testing
-
Overview of Infectious Disease Testing
-
Market Outlook
-
Regional Market
-
Company Briefs
-
Roche
-
Abbott
-
Danaher
-
Other Participants
-
Executive News Briefing
-
Briefings
-
Dxcover Limited Raises New Capital
-
Cubit Diagnostics Awarded NIH Funding
-
CARB-X Funds AstraDx’s Neonatal Sepsis Rapid Test
-
Freenome Raises Additional $254 Million
-
Renovaro Secures $15 Million in New Capital
-
Ataraxis AI Secures $20.4 Million in Funding
-
MSInsight Nabs €1.6 Million Seed Funding
-
C2N Diagnostics Receives $10 Million Investment
-
Financial Highlights: Guardant Health, Roche
-
Guardant Reports Strong Demand – Increasing Revenues +31% Over Previous Year
-
Roche Diagnostic Sales Grow 4% CER in 2024 – Supported by Demand for Immunodiagnostics, Pathology, and Molecular Solutions
-
Diagnostic Market Mergers, Acquisitions, and Partnership Deals
-
Mergers and Acquisitions
-
Partnerships and Collaborations
-
Industry Watch
-
Industry Watch COVID-19/Flu Update
-
Region Watch
-
Broad-based Company Announcements
-
Announcements
-
AliveDx Nabs CE Mark for Expanded Autoimmune Menu
-
Beckman Coulter Received FDA Breakthrough Device Designation
-
Beckton Dickinson to Spin Off Bioscience and Diagnostic Business
-
GRAIL Provides Galleri Multi-Cancer Early Detection Test Through Quest
-
Molecular Instruments RNA-ISH Enables Breakthrough LDT
-
Roche Snags FDA Clearance for Preeclampsia Test
-
CytoChip Receives FDA Clearance and CLIA Waiver
-
Cicero Diagnostics Unveiled Endometriosis Detection LDT
-
bioMérieux Secures FDA Clearance for BIOFIRE FILMARRAY GI Panel
-
Beckman Coulter Gains Clearance for its DxC 500i
|
More information about this product
Other Users Also Viewed
18 Jul 2019
Customer experience in the clinical diagnostics industry is increasingly a target for improving overall customer satisfaction and a potential opportunity for differentiation beyond product performance, service plans, and price. This Kalorama Informa…
|
